MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eleven analysts that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 1 year target price among brokers […]
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives $73 42 Consensus Target Price from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Polar Capital Holdings Plc lessened its holdings in MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) by 41.9% during the third quarter, HoldingsChannel.com reports. The firm owned 939,012 shares of the company’s stock after selling 676,377 shares during the period. Polar Capital Holdings Plc’s holdings in MoonLake Immunotherapeutics were worth $53,524,000 as of its most recent SEC […]
Fred Alger Management LLC Raises Holdings in MoonLake Immunotherapeutics (NASDAQ:MLTX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
MoonLake Immunotherapeutics (NASDAQ:MLTX) Holdings Decreased by Westfield Capital Management Co LP themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.